Pages that link to "Q37171242"
Jump to navigation
Jump to search
The following pages link to The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs (Q37171242):
Displaying 15 items.
- Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking (Q27011482) (← links)
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs (Q28066801) (← links)
- An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. (Q33615268) (← links)
- Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery (Q33825880) (← links)
- Copper-free click-chemistry platform to functionalize cisplatin prodrugs. (Q35133330) (← links)
- Encapsulation of lipophilic kiteplatin Pt(iv) prodrugs in PLGA-PEG micelles. (Q35993977) (← links)
- Target-selective delivery and activation of platinum-based anticancer agents (Q38523600) (← links)
- Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer. (Q38729106) (← links)
- Featured Article: Nanoenhanced matrix metalloproteinase-responsive delivery vehicles for disease resolution and imaging (Q38754729) (← links)
- Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy (Q38762779) (← links)
- Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models. (Q47721500) (← links)
- Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer (Q50326340) (← links)
- Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. (Q52598486) (← links)
- Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance (Q60284327) (← links)
- Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy (Q93366667) (← links)